Orama-Med is a boutique firm established on beginning of 2015 by Ehud Almon to exploit the opportunities and facilitates business cooperation between entrepreneurs, organizations and companies of Greece and Israel. The company has initiated and concluded cooperation between Greek and Israeli entrepreneurs, research institutes, start-ups, VC’s and mature companies that operate in the domains of medical devices, biotech, digital health, medical cannabis, health organizations, food-tech, agro-tech and clean-tech. It assists its clients with the tedious process as from generating and qualifying leads to getting meetings with promising partners and initiating cooperation. Orama-Med has a successful track record in facilitating R&D collaboration, distribution agreements, JV’s and strategic partnerships. To list few could mention cooperation with three medical cannabis projects in Greece that has already obtained licenses; Representing in Greece and the region Gemmacert (https://gemmacert.com/), Eybna (https://www.eybna.com/), Seedo (https://www.seedolab.com/) and other innovative companies and technologies that serve the cannabis industry; Establishing together with Prof. Konstantinos Poulas of the faculty of Pharmacies at Patras university the Kannabis Team (https://kannabis.gr/); Cooperation with Collplant Ltd (http://www.collplant.com/) in launching and distribution their VerganixFG wound care product; Initiating a cooperation and concluding a JV between Orgenesis Inc. and Theracell Biotechnology; Cooperating with Regenera Pharma (https://www.regenerapharma.com/) in sourcing and securing their Mastiha Gum raw material for the production of their botanical candidate drug rp201, which’s currently in phase-III clinical trials in the U.S.; Co-founder of TendoMend Ltd in cooperation with a leading Greek orthopedic surgeon. TendoMend is a medical device start-up which has developed a device for treating tendon ruptures and recently raised seeds funding from NGT3 VC (http://www.ngt3vc.com/).